Lawyers value a hernia-mesh revision case on proof of severe, documented harm and clear linkage to a specific failed implant. Trial risk stays high because past bellwether trials produced both a defense win and multimillion-dollar plaintiff verdicts. Surgical mesh is a material that reinforces weak tissue during hernia repair.
A revision means a later operation to fix, remove, or replace that mesh after pain, infection, or recurrence. The U.S. Food and Drug Administration states that hernia-repair mesh can cause pain, infection, recurrence, adhesion, bowel obstruction, and organ perforation requiring further treatment FDA page on surgical mesh for hernia repair.
Official resources:
- Read the official guidance from FDA — Use this primary source to verify the official guidance.
- Read the official notice from Bd — Use this primary source to verify the official announcement.
Table of Contents
- What revision injuries carry the most weight?
- How did the large Bard settlement value claims?
- What do bellwether verdicts say about trial risk?
- Will a lawyer accept a new Bard revision case?
What revision injuries carry the most weight?
Doyle APC reports allegations involving Bard Davol polypropylene meshes, including Ventralex, Ventralight ST, PerFix Plug and 3DMax. The allegation is that the mesh can migrate, contract, adhere to bowel, erode, and cause infection and chronic pain requiring revision or removal surgery.
Lawyers treat objective operative findings as stronger than pain reports alone. Bowel involvement, resection, fistula, or infected-mesh removal usually signals higher damages and clearer causation. A single recurrence repair without mesh failure proof carries less weight.
How did the large Bard settlement value claims?
Becton, Dickinson and Company announced on October 2, 2024 that it had agreed to resolve the vast majority of existing U.S. hernia-mesh litigation. The company said administration would follow over several years.
Legal500, summarizing Siskinds LLP, reported that the Bard settlement covered about 38,000 federal and state cases and exceeded $1 billion Legal500 report on the settlement. The same report describes allocation through a points-based system tied to injury severity. Severity therefore set payment tiers, not a flat amount per revision.
What do bellwether verdicts say about trial risk?
According to Doyle APC, Bard bellwether trials show split trial risk. The defense won the first federal bellwether. Later plaintiff verdicts included about $255,000 and $500,000 federally and $4.8 million in Rhode Island state court in 2022 Doyle APC review of Bard hernia-mesh lawsuits.
ConsumerNotice reported a large verdict outside Bard in its November 2026 update ConsumerNotice settlements update. The first Patterson bellwether in the separate Covidien hernia-mesh MDL ended in an $88 million verdict in August 2026. That gap warns that settlement value and trial outcome can diverge sharply by defendant and facts.
Will a lawyer accept a new Bard revision case?
Doyle APC says lawyers now screen new Bard cases on documented severity. General pain or one simple recurrence repair is usually not enough.
According to the same Doyle APC review, firms also require operative proof of Bard mesh and a live limitations period. Get the implant sticker, operative reports, pathology, and infection treatment records before the call. A deadline can bar an otherwise severe claim.
- two or more revisions
- bowel resection
- fistula
- surgical obstruction
- infected mesh removal
You Might Also Like
- A Bellwether Trial Producing an Unexpected Defense Verdict: How Would a Settlement Matrix Value Different Claims?
- A Hernia Mesh Implant Followed by Revision Surgery: Does the Conduct Rise From Negligence to Gross Negligence?
- A Mass-Tort Settlement Using a Point-Based Matrix: What Happens to Cases That Settle, Get Dismissed, or Return for Trial?